Efficacy of PLEM100(Inbody®) in Children

NCT03195686 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2018-11-14

No results posted yet for this study

Summary

Evaluation of efficacy of PLEM100(Inbody®) in measuring the sedation level in pediatric patients

Conditions

  • Development, Child

Interventions

DEVICE

PLE100(Inbody®)

PLE100(Inbody®) monitoring in children to be operated under the total intravenous anesthesia (Propofol)

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Hee-Soo Kim, PhD · Seoul National University Hospital

Eligibility

Min Age
3 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-15
Primary Completion
2018-07-29
Completion
2018-07-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03195686 on ClinicalTrials.gov